<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>AZD0780 - Oral PCSK9 Inhibitor | Leaf Intelligence</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <style>
        /* Custom animations matching your project */
        @keyframes fadeInRow {
            from { opacity: 0; transform: translateY(10px); }
            to { opacity: 1; transform: translateY(0); }
        }
        @keyframes pulse {
            0%, 100% { opacity: 0.5; transform: scale(0.95); }
            50% { opacity: 0.8; transform: scale(1.1); }
        }
        @keyframes slideIn {
            from { opacity: 0; transform: translateX(-10px); }
            to { opacity: 1; transform: translateX(0); }
        }
        .animate-fade-in-row { animation: fadeInRow 0.3s ease forwards; }
        .animate-pulse-glow { animation: pulse 3s ease-in-out infinite; }
        .animate-slide-in { animation: slideIn 0.6s ease-out forwards; }
        
        /* Custom scrollbar */
        ::-webkit-scrollbar { width: 8px; height: 8px; }
        ::-webkit-scrollbar-track { @apply bg-gray-100 dark:bg-gray-800 rounded; }
        ::-webkit-scrollbar-thumb { @apply bg-gray-400 dark:bg-gray-600 rounded hover:bg-gray-500 dark:hover:bg-gray-500; }
        
        /* Glass effect */
        .glass {
            background: rgba(255, 255, 255, 0.75);
            backdrop-filter: blur(20px);
            -webkit-backdrop-filter: blur(20px);
        }
        .dark .glass {
            background: rgba(17, 24, 39, 0.75);
        }
    </style>
</head>
<body class="bg-gray-50 dark:bg-gray-900 transition-all duration-300">
    <!-- Fixed Header (matching your project) -->
    <header class="fixed top-0 left-0 right-0 z-50 glass border-b border-gray-200 dark:border-gray-700 shadow-lg">
        <div class="max-w-7xl mx-auto px-4 sm:px-6 lg:px-8">
            <div class="flex justify-between items-center py-4">
                <!-- Logo -->
                <div class="flex items-center space-x-3">
                    <div class="relative">
                        <img src="leaf.png" alt="Leaf Intelligence" class="h-12 w-12 relative z-10">
                        <div class="absolute inset-0 bg-gradient-to-r from-green-400 to-cyan-400 opacity-20 blur-xl animate-pulse-glow"></div>
                    </div>
                    <div>
                        <div class="text-xl font-light bg-gradient-to-r from-green-600 to-cyan-600 dark:from-green-400 dark:to-cyan-400 bg-clip-text text-transparent">
                            Leaf Intelligence
                        </div>
                        <div class="text-xs text-gray-600 dark:text-gray-400 font-light">
                            Cholesterol Therapies Analysis
                        </div>
                    </div>
                </div>

                <!-- Navigation -->
                <nav class="hidden md:flex items-center space-x-1 bg-gray-100/50 dark:bg-gray-800/50 p-1.5 rounded-lg backdrop-blur-sm">
                    <a href="index.html" class="px-5 py-2 rounded-md text-sm font-medium transition-all duration-200 text-gray-600 dark:text-gray-400 hover:text-gray-900 dark:hover:text-white hover:bg-white/50 dark:hover:bg-gray-700/50">
                        Overview
                    </a>
                    <a href="index.html#approved" class="px-5 py-2 rounded-md text-sm font-medium transition-all duration-200 text-gray-600 dark:text-gray-400 hover:text-gray-900 dark:hover:text-white hover:bg-white/50 dark:hover:bg-gray-700/50">
                        Competitors
                    </a>
                    <button class="px-5 py-2 rounded-md text-sm font-medium transition-all duration-200 text-gray-900 dark:text-white bg-white/50 dark:bg-gray-700/50 active">
                        Drug Profile
                    </button>
                </nav>

                <!-- Theme Toggle -->
                <!-- <button onclick="toggleTheme()" class="relative w-14 h-7 rounded-full bg-gray-200 dark:bg-gray-700 transition-all duration-300 shadow-inner hover:shadow-md">
                    <div class="absolute top-0.5 left-0.5 w-6 h-6 rounded-full bg-white dark:bg-gray-900 shadow-lg transform transition-transform duration-300 dark:translate-x-7 flex items-center justify-center">
                        <svg class="w-4 h-4 text-yellow-500 dark:hidden" fill="currentColor" viewBox="0 0 24 24">
                            <path d="M12 7a5 5 0 100 10 5 5 0 000-10z"/>
                        </svg>
                        <svg class="w-4 h-4 text-indigo-400 hidden dark:block" fill="currentColor" viewBox="0 0 24 24">
                            <path d="M21 12.79A9 9 0 1111.21 3 7 7 0 0021 12.79z"/>
                        </svg>
                    </div>
                </button> -->
            </div>
        </div>
    </header>

    <!-- Main Container with padding for fixed header -->
    <div class="pt-20 min-h-screen">
        <div class="max-w-7xl mx-auto px-4 sm:px-6 lg:px-8 py-8">
            
            <!-- Hero Section -->
            <div class="glass rounded-2xl p-8 mb-8 border border-gray-200 dark:border-gray-700">
                <div class="flex justify-between items-start">
                    <div>
                        <h1 class="text-4xl font-light mb-2 text-gray-900 dark:text-white">
                            AZD0780
                        </h1>
                        <p class="text-lg text-indigo-600 dark:text-indigo-400 mb-2">
                            Oral PCSK9 Inhibitor (Small Molecule)
                        </p>
                        <p class="text-sm text-gray-600 dark:text-gray-400">
                            AstraZeneca | Phase III Ongoing
                        </p>
                    </div>
                    <div class="flex gap-2">
                        <a href="https://clinicaltrials.gov/search?term=AZD0780" target="_blank" class="inline-flex items-center px-4 py-2 text-sm font-medium rounded-lg bg-gradient-to-r from-indigo-600 to-purple-600 text-white hover:from-indigo-700 hover:to-purple-700 transition-all">
                            ClinicalTrials.gov
                        </a>
                        <a href="https://www.astrazeneca.com/our-therapy-areas/cardiovascular-renal-metabolism.html" target="_blank" class="inline-flex items-center px-4 py-2 text-sm font-medium rounded-lg border border-gray-300 dark:border-gray-600 text-gray-700 dark:text-gray-300 hover:bg-gray-50 dark:hover:bg-gray-800 transition-all">
                            AstraZeneca Pipeline
                        </a>
                    </div>
                </div>
            </div>

            <!-- Quick Stats -->
            <div class="grid grid-cols-2 md:grid-cols-4 gap-4 mb-8">
                <div class="glass rounded-xl p-4 border border-gray-200 dark:border-gray-700 hover:shadow-lg transition-shadow">
                    <div class="text-2xl font-bold text-indigo-600 dark:text-indigo-400">50.7%</div>
                    <div class="text-xs text-gray-600 dark:text-gray-400 uppercase tracking-wider mt-1">LDL-C Reduction</div>
                </div>
                <div class="glass rounded-xl p-4 border border-gray-200 dark:border-gray-700 hover:shadow-lg transition-shadow">
                    <div class="text-2xl font-bold text-green-600 dark:text-green-400">30 mg</div>
                    <div class="text-xs text-gray-600 dark:text-gray-400 uppercase tracking-wider mt-1">Daily Dose</div>
                </div>
                <div class="glass rounded-xl p-4 border border-gray-200 dark:border-gray-700 hover:shadow-lg transition-shadow">
                    <div class="text-2xl font-bold text-purple-600 dark:text-purple-400">Phase III</div>
                    <div class="text-xs text-gray-600 dark:text-gray-400 uppercase tracking-wider mt-1">Current Status</div>
                </div>
                <div class="glass rounded-xl p-4 border border-gray-200 dark:border-gray-700 hover:shadow-lg transition-shadow">
                    <div class="text-2xl font-bold text-amber-600 dark:text-amber-400">2027</div>
                    <div class="text-xs text-gray-600 dark:text-gray-400 uppercase tracking-wider mt-1">Est. Approval</div>
                </div>
            </div>

            <!-- Tab Navigation -->
            <div class="glass rounded-xl mb-4 border border-gray-200 dark:border-gray-700">
                <div class="flex overflow-x-auto">
                    <button class="nav-tab px-6 py-3 text-sm font-medium transition-all text-indigo-600 dark:text-indigo-400 border-b-2 border-indigo-600 dark:border-indigo-400" onclick="showTab('overview')">
                        Overview
                    </button>
                    <button class="nav-tab px-6 py-3 text-sm font-medium transition-all text-gray-600 dark:text-gray-400 hover:text-gray-900 dark:hover:text-white" onclick="showTab('mechanism')">
                        Mechanism
                    </button>
                    <button class="nav-tab px-6 py-3 text-sm font-medium transition-all text-gray-600 dark:text-gray-400 hover:text-gray-900 dark:hover:text-white" onclick="showTab('clinical')">
                        Clinical Trials
                    </button>
                    <button class="nav-tab px-6 py-3 text-sm font-medium transition-all text-gray-600 dark:text-gray-400 hover:text-gray-900 dark:hover:text-white" onclick="showTab('safety')">
                        Safety
                    </button>
                    <button class="nav-tab px-6 py-3 text-sm font-medium transition-all text-gray-600 dark:text-gray-400 hover:text-gray-900 dark:hover:text-white" onclick="showTab('regulatory')">
                        Regulatory
                    </button>
                    <button class="nav-tab px-6 py-3 text-sm font-medium transition-all text-gray-600 dark:text-gray-400 hover:text-gray-900 dark:hover:text-white" onclick="showTab('commercial')">
                        Commercial
                    </button>
                </div>
            </div>

            <!-- Tab Content -->
            <!-- Overview Tab -->
            <div class="tab-content" id="overview">
                <div class="grid grid-cols-1 lg:grid-cols-3 gap-6">
                    <!-- Key Features -->
                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700">
                        <h3 class="text-lg font-light text-gray-900 dark:text-white mb-4 flex items-center gap-2">
                            <span class="text-indigo-600 dark:text-indigo-400">🔬</span> Key Features
                        </h3>
                        <ul class="space-y-2 text-sm text-gray-600 dark:text-gray-400">
                            <li class="flex items-start">
                                <span class="text-green-500 mr-2">✓</span>
                                First true oral small molecule PCSK9 inhibitor
                            </li>
                            <li class="flex items-start">
                                <span class="text-green-500 mr-2">✓</span>
                                Once-daily dosing (30 mg)
                            </li>
                            <li class="flex items-start">
                                <span class="text-green-500 mr-2">✓</span>
                                No meal restrictions required
                            </li>
                            <li class="flex items-start">
                                <span class="text-green-500 mr-2">✓</span>
                                ~50% LDL-C reduction achieved
                            </li>
                            <li class="flex items-start">
                                <span class="text-green-500 mr-2">✓</span>
                                UK Innovation Passport (2023)
                            </li>
                            <li class="flex items-start">
                                <span class="text-green-500 mr-2">✓</span>
                                Potential neuroprotective effects
                            </li>
                        </ul>
                    </div>

                    <!-- Clinical Highlights -->
                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700">
                        <h3 class="text-lg font-light text-gray-900 dark:text-white mb-4 flex items-center gap-2">
                            <span class="text-purple-600 dark:text-purple-400">📊</span> Clinical Highlights
                        </h3>
                        <ul class="space-y-2 text-sm text-gray-600 dark:text-gray-400">
                            <li class="flex items-start">
                                <span class="text-blue-500 mr-2">•</span>
                                Phase IIb PURSUIT: 50.7% LDL reduction
                            </li>
                            <li class="flex items-start">
                                <span class="text-blue-500 mr-2">•</span>
                                84% patients achieved LDL <70 mg/dL
                            </li>
                            <li class="flex items-start">
                                <span class="text-blue-500 mr-2">•</span>
                                Consistent efficacy across statin intensities
                            </li>
                            <li class="flex items-start">
                                <span class="text-blue-500 mr-2">•</span>
                                PCSK9 reduction >90%
                            </li>
                            <li class="flex items-start">
                                <span class="text-blue-500 mr-2">•</span>
                                Phase III trials recruiting (n>13,000)
                            </li>
                            <li class="flex items-start">
                                <span class="text-blue-500 mr-2">•</span>
                                MACE outcomes trial through 2029
                            </li>
                        </ul>
                    </div>

                    <!-- Strategic Position -->
                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700">
                        <h3 class="text-lg font-light text-gray-900 dark:text-white mb-4 flex items-center gap-2">
                            <span class="text-amber-600 dark:text-amber-400">🎯</span> Strategic Position
                        </h3>
                        <ul class="space-y-2 text-sm text-gray-600 dark:text-gray-400">
                            <li class="flex items-start">
                                <span class="text-amber-500 mr-2">→</span>
                                Part of AZ's $80B CVRM portfolio target
                            </li>
                            <li class="flex items-start">
                                <span class="text-amber-500 mr-2">→</span>
                                Menarini partnership for EU distribution
                            </li>
                            <li class="flex items-start">
                                <span class="text-amber-500 mr-2">→</span>
                                Fixed-dose combinations in development
                            </li>
                            <li class="flex items-start">
                                <span class="text-amber-500 mr-2">→</span>
                                Competing with Merck's MK-0616
                            </li>
                            <li class="flex items-start">
                                <span class="text-amber-500 mr-2">→</span>
                                Projected $1-5B market by 2030
                            </li>
                            <li class="flex items-start">
                                <span class="text-amber-500 mr-2">→</span>
                                Patent protection to late 2030s
                            </li>
                        </ul>
                    </div>
                </div>

                <!-- Unique Differentiation Box -->
                <div class="glass rounded-xl p-6 mt-6 border border-gray-200 dark:border-gray-700 bg-gradient-to-r from-indigo-50/50 to-purple-50/50 dark:from-indigo-900/10 dark:to-purple-900/10">
                    <h3 class="text-lg font-light text-gray-900 dark:text-white mb-3">🌟 Unique Differentiation</h3>
                    <p class="text-sm text-gray-600 dark:text-gray-400 leading-relaxed">
                        AZD0780 stands out as the first traditional small molecule PCSK9 inhibitor (vs peptide-based competitors), 
                        with potential advantages in manufacturing scalability and tissue distribution. Preliminary data showing 
                        reduction in Alzheimer's biomarkers (CSF p-tau217) suggests possible neuroprotective benefits beyond 
                        cardiovascular effects, though this remains exploratory.
                    </p>
                </div>

                <!-- Live Data Links -->
                <div class="glass rounded-xl p-6 mt-6 border border-gray-200 dark:border-gray-700">
                    <h3 class="text-lg font-light text-gray-900 dark:text-white mb-4">📈 Live Data & Resources</h3>
                    <div class="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-3 gap-3">
                        <a href="https://clinicaltrials.gov/study/NCT06173570" target="_blank" class="flex items-center gap-2 px-4 py-2 rounded-lg bg-white dark:bg-gray-800 border border-gray-200 dark:border-gray-600 hover:border-indigo-500 transition-colors">
                            <span class="text-blue-600">🔗</span>
                            <span class="text-sm text-gray-700 dark:text-gray-300">PURSUIT Trial (NCT06173570)</span>
                        </a>
                        <a href="https://clinicaltrials.gov/study/NCT07000136" target="_blank" class="flex items-center gap-2 px-4 py-2 rounded-lg bg-white dark:bg-gray-800 border border-gray-200 dark:border-gray-600 hover:border-indigo-500 transition-colors">
                            <span class="text-blue-600">🔗</span>
                            <span class="text-sm text-gray-700 dark:text-gray-300">Phase III ASCVD (NCT07000136)</span>
                        </a>
                        <a href="https://clinicaltrials.gov/study/NCT07000123" target="_blank" class="flex items-center gap-2 px-4 py-2 rounded-lg bg-white dark:bg-gray-800 border border-gray-200 dark:border-gray-600 hover:border-indigo-500 transition-colors">
                            <span class="text-blue-600">🔗</span>
                            <span class="text-sm text-gray-700 dark:text-gray-300">Phase III HeFH (NCT07000123)</span>
                        </a>
                        <a href="https://www.leaf.health/search?q=AZD0780" target="_blank" class="flex items-center gap-2 px-4 py-2 rounded-lg bg-white dark:bg-gray-800 border border-gray-200 dark:border-gray-600 hover:border-indigo-500 transition-colors">
                            <span class="text-green-600">🍃</span>
                            <span class="text-sm text-gray-700 dark:text-gray-300">Leaf Intelligence Search</span>
                        </a>
                        <a href="https://pubmed.ncbi.nlm.nih.gov/?term=AZD0780" target="_blank" class="flex items-center gap-2 px-4 py-2 rounded-lg bg-white dark:bg-gray-800 border border-gray-200 dark:border-gray-600 hover:border-indigo-500 transition-colors">
                            <span class="text-purple-600">📚</span>
                            <span class="text-sm text-gray-700 dark:text-gray-300">PubMed Publications</span>
                        </a>
                        <a href="https://www.fda.gov/drugs/development-approval-process-drugs" target="_blank" class="flex items-center gap-2 px-4 py-2 rounded-lg bg-white dark:bg-gray-800 border border-gray-200 dark:border-gray-600 hover:border-indigo-500 transition-colors">
                            <span class="text-red-600">🏛️</span>
                            <span class="text-sm text-gray-700 dark:text-gray-300">FDA Drug Database</span>
                        </a>
                    </div>
                </div>
            </div>

            <!-- Mechanism Tab -->
            <div class="tab-content hidden" id="mechanism">
                <div class="glass rounded-xl p-6 mb-6 border border-gray-200 dark:border-gray-700">
                    <h3 class="text-xl font-light text-gray-900 dark:text-white mb-4">⚙️ Mechanism of Action</h3>
                    <p class="text-sm text-gray-600 dark:text-gray-400 leading-relaxed mb-4">
                        AZD0780 is an investigational <span class="font-medium text-indigo-600 dark:text-indigo-400">oral small-molecule inhibitor of PCSK9</span>. 
                        It binds with high affinity to the <span class="font-medium text-indigo-600 dark:text-indigo-400">C-terminal domain of PCSK9</span>, 
                        stabilizing the PCSK9-LDL receptor (LDL-R) complex and preventing PCSK9-mediated lysosomal degradation 
                        of LDL-R on hepatocytes.
                    </p>
                    <ul class="space-y-2 text-sm text-gray-600 dark:text-gray-400">
                        <li class="flex items-start">
                            <span class="text-green-500 mr-2">•</span>
                            Increased recycling and surface expression of LDL-R
                        </li>
                        <li class="flex items-start">
                            <span class="text-green-500 mr-2">•</span>
                            Enhanced hepatic uptake and clearance of LDL-C
                        </li>
                        <li class="flex items-start">
                            <span class="text-green-500 mr-2">•</span>
                            Substantial reductions in serum LDL-C levels (~50%)
                        </li>
                        <li class="flex items-start">
                            <span class="text-green-500 mr-2">•</span>
                            >90% reduction in free PCSK9 levels
                        </li>
                    </ul>
                </div>

                <!-- Dosing Grid -->
                <div class="grid grid-cols-2 md:grid-cols-3 gap-4">
                    <div class="glass rounded-xl p-4 border border-gray-200 dark:border-gray-700 hover:shadow-lg transition-shadow">
                        <div class="text-xs text-gray-500 dark:text-gray-400 uppercase tracking-wider mb-1">Administration</div>
                        <div class="text-xl font-bold text-gray-900 dark:text-white">Oral, QD</div>
                        <div class="text-xs text-gray-600 dark:text-gray-400 mt-1">Once-daily tablet</div>
                    </div>
                    <div class="glass rounded-xl p-4 border border-gray-200 dark:border-gray-700 hover:shadow-lg transition-shadow">
                        <div class="text-xs text-gray-500 dark:text-gray-400 uppercase tracking-wider mb-1">Primary Dose</div>
                        <div class="text-xl font-bold text-gray-900 dark:text-white">30 mg</div>
                        <div class="text-xs text-gray-600 dark:text-gray-400 mt-1">Phase IIb optimal dose</div>
                    </div>
                    <div class="glass rounded-xl p-4 border border-gray-200 dark:border-gray-700 hover:shadow-lg transition-shadow">
                        <div class="text-xs text-gray-500 dark:text-gray-400 uppercase tracking-wider mb-1">Dose Range</div>
                        <div class="text-xl font-bold text-gray-900 dark:text-white">5-60 mg</div>
                        <div class="text-xs text-gray-600 dark:text-gray-400 mt-1">Evaluated in trials</div>
                    </div>
                    <div class="glass rounded-xl p-4 border border-gray-200 dark:border-gray-700 hover:shadow-lg transition-shadow">
                        <div class="text-xs text-gray-500 dark:text-gray-400 uppercase tracking-wider mb-1">Food Requirements</div>
                        <div class="text-xl font-bold text-gray-900 dark:text-white">None</div>
                        <div class="text-xs text-gray-600 dark:text-gray-400 mt-1">Can be taken without meals</div>
                    </div>
                    <div class="glass rounded-xl p-4 border border-gray-200 dark:border-gray-700 hover:shadow-lg transition-shadow">
                        <div class="text-xs text-gray-500 dark:text-gray-400 uppercase tracking-wider mb-1">Onset</div>
                        <div class="text-xl font-bold text-gray-900 dark:text-white">2 weeks</div>
                        <div class="text-xs text-gray-600 dark:text-gray-400 mt-1">LDL-C reduction begins</div>
                    </div>
                    <div class="glass rounded-xl p-4 border border-gray-200 dark:border-gray-700 hover:shadow-lg transition-shadow">
                        <div class="text-xs text-gray-500 dark:text-gray-400 uppercase tracking-wider mb-1">Steady State</div>
                        <div class="text-xl font-bold text-gray-900 dark:text-white">4-12 weeks</div>
                        <div class="text-xs text-gray-600 dark:text-gray-400 mt-1">Full effect achieved</div>
                    </div>
                </div>
            </div>

            <!-- Clinical Trials Tab -->
            <div class="tab-content hidden" id="clinical">
                <div class="glass rounded-xl overflow-hidden border border-gray-200 dark:border-gray-700">
                    <div class="overflow-x-auto">
                        <table class="w-full">
                            <thead class="bg-gray-50 dark:bg-gray-800 border-b border-gray-200 dark:border-gray-700">
                                <tr>
                                    <th class="px-6 py-4 text-left text-xs font-medium text-gray-700 dark:text-gray-300 uppercase tracking-wider">Trial</th>
                                    <th class="px-6 py-4 text-left text-xs font-medium text-gray-700 dark:text-gray-300 uppercase tracking-wider">Phase</th>
                                    <th class="px-6 py-4 text-left text-xs font-medium text-gray-700 dark:text-gray-300 uppercase tracking-wider">Population</th>
                                    <th class="px-6 py-4 text-left text-xs font-medium text-gray-700 dark:text-gray-300 uppercase tracking-wider">N</th>
                                    <th class="px-6 py-4 text-left text-xs font-medium text-gray-700 dark:text-gray-300 uppercase tracking-wider">Primary Endpoint</th>
                                    <th class="px-6 py-4 text-left text-xs font-medium text-gray-700 dark:text-gray-300 uppercase tracking-wider">Results/Status</th>
                                    <th class="px-6 py-4 text-left text-xs font-medium text-gray-700 dark:text-gray-300 uppercase tracking-wider">Actions</th>
                                </tr>
                            </thead>
                            <tbody class="divide-y divide-gray-200 dark:divide-gray-700">
                                <tr class="hover:bg-gray-50 dark:hover:bg-gray-800 transition-colors">
                                    <td class="px-6 py-4 text-sm text-gray-900 dark:text-white">Phase I<br><small class="text-gray-500">2023-2024</small></td>
                                    <td class="px-6 py-4">
                                        <span class="inline-flex items-center px-2.5 py-0.5 rounded-full text-xs font-medium bg-blue-100 dark:bg-blue-900/30 text-blue-800 dark:text-blue-400">Phase I</span>
                                    </td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">Healthy/Hypercholesterolemia</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">~100</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">Safety/PK/PD</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">52% LDL-C reduction</td>
                                    <td class="px-6 py-4">
                                        <span class="text-xs text-green-600">Complete</span>
                                    </td>
                                </tr>
                                <tr class="hover:bg-gray-50 dark:hover:bg-gray-800 transition-colors">
                                    <td class="px-6 py-4 text-sm text-gray-900 dark:text-white">PURSUIT<br><small class="text-gray-500">NCT06173570</small></td>
                                    <td class="px-6 py-4">
                                        <span class="inline-flex items-center px-2.5 py-0.5 rounded-full text-xs font-medium bg-purple-100 dark:bg-purple-900/30 text-purple-800 dark:text-purple-400">Phase IIb</span>
                                    </td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">Hyperlipidemia</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">428</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">% LDL-C at week 12</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">50.7% reduction</td>
                                    <td class="px-6 py-4">
                                        <a href="https://clinicaltrials.gov/study/NCT06173570" target="_blank" class="text-xs text-indigo-600 hover:underline">View →</a>
                                    </td>
                                </tr>
                                <tr class="hover:bg-gray-50 dark:hover:bg-gray-800 transition-colors">
                                    <td class="px-6 py-4 text-sm text-gray-900 dark:text-white">D7960C00012<br><small class="text-gray-500">NCT07000136</small></td>
                                    <td class="px-6 py-4">
                                        <span class="inline-flex items-center px-2.5 py-0.5 rounded-full text-xs font-medium bg-green-100 dark:bg-green-900/30 text-green-800 dark:text-green-400">Phase III</span>
                                    </td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">ASCVD/High-risk</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">~2,500</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">% LDL-C at week 24</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">Ongoing</td>
                                    <td class="px-6 py-4">
                                        <a href="https://clinicaltrials.gov/study/NCT07000136" target="_blank" class="text-xs text-indigo-600 hover:underline">View →</a>
                                    </td>
                                </tr>
                                <tr class="hover:bg-gray-50 dark:hover:bg-gray-800 transition-colors">
                                    <td class="px-6 py-4 text-sm text-gray-900 dark:text-white">D7960C00015<br><small class="text-gray-500">NCT07000357</small></td>
                                    <td class="px-6 py-4">
                                        <span class="inline-flex items-center px-2.5 py-0.5 rounded-full text-xs font-medium bg-green-100 dark:bg-green-900/30 text-green-800 dark:text-green-400">Phase III</span>
                                    </td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">ASCVD</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">~10,000</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">MACE outcomes</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">Enrolling (~2029)</td>
                                    <td class="px-6 py-4">
                                        <a href="https://clinicaltrials.gov/study/NCT07000357" target="_blank" class="text-xs text-indigo-600 hover:underline">View →</a>
                                    </td>
                                </tr>
                            </tbody>
                        </table>
                    </div>
                </div>

                <!-- Efficacy Chart -->
                <div class="glass rounded-xl p-6 mt-6 border border-gray-200 dark:border-gray-700">
                    <h3 class="text-lg font-light text-gray-900 dark:text-white mb-4">LDL-C Reduction Across Trials</h3>
                    <div class="grid grid-cols-2 md:grid-cols-4 gap-4">
                        <div class="text-center">
                            <div class="h-32 flex items-end justify-center mb-2">
                                <div class="w-16 bg-gradient-to-t from-indigo-600 to-purple-600 rounded-t-lg" style="height: 52%;"></div>
                            </div>
                            <div class="text-2xl font-bold text-indigo-600 dark:text-indigo-400">52%</div>
                            <div class="text-xs text-gray-600 dark:text-gray-400">Phase I +Statin</div>
                        </div>
                        <div class="text-center">
                            <div class="h-32 flex items-end justify-center mb-2">
                                <div class="w-16 bg-gradient-to-t from-indigo-600 to-purple-600 rounded-t-lg" style="height: 78%;"></div>
                            </div>
                            <div class="text-2xl font-bold text-indigo-600 dark:text-indigo-400">78%</div>
                            <div class="text-xs text-gray-600 dark:text-gray-400">Phase I Total</div>
                        </div>
                        <div class="text-center">
                            <div class="h-32 flex items-end justify-center mb-2">
                                <div class="w-16 bg-gradient-to-t from-indigo-600 to-purple-600 rounded-t-lg" style="height: 52%;"></div>
                            </div>
                            <div class="text-2xl font-bold text-indigo-600 dark:text-indigo-400">52%</div>
                            <div class="text-xs text-gray-600 dark:text-gray-400">Phase IIa</div>
                        </div>
                        <div class="text-center">
                            <div class="h-32 flex items-end justify-center mb-2">
                                <div class="w-16 bg-gradient-to-t from-indigo-600 to-purple-600 rounded-t-lg" style="height: 50.7%;"></div>
                            </div>
                            <div class="text-2xl font-bold text-indigo-600 dark:text-indigo-400">50.7%</div>
                            <div class="text-xs text-gray-600 dark:text-gray-400">PURSUIT</div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Safety Tab -->
            <div class="tab-content hidden" id="safety">
                <div class="grid grid-cols-2 md:grid-cols-3 gap-4 mb-6">
                    <div class="glass rounded-xl p-6 text-center border border-gray-200 dark:border-gray-700">
                        <div class="text-3xl font-bold text-indigo-600 dark:text-indigo-400 mb-2">38.2%</div>
                        <div class="text-sm text-gray-600 dark:text-gray-400">Overall AEs (Drug)</div>
                    </div>
                    <div class="glass rounded-xl p-6 text-center border border-gray-200 dark:border-gray-700">
                        <div class="text-3xl font-bold text-gray-600 dark:text-gray-400 mb-2">32.6%</div>
                        <div class="text-sm text-gray-600 dark:text-gray-400">Overall AEs (Placebo)</div>
                    </div>
                    <div class="glass rounded-xl p-6 text-center border border-gray-200 dark:border-gray-700">
                        <div class="text-3xl font-bold text-green-600 dark:text-green-400 mb-2">3%</div>
                        <div class="text-sm text-gray-600 dark:text-gray-400">Serious AEs</div>
                    </div>
                </div>

                <div class="grid grid-cols-1 md:grid-cols-2 gap-6">
                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700">
                        <h3 class="text-lg font-light text-gray-900 dark:text-white mb-4">✓ Common Adverse Events (>5%)</h3>
                        <ul class="space-y-2 text-sm text-gray-600 dark:text-gray-400">
                            <li>• Headache (6-8%)</li>
                            <li>• Nausea (4-6%, mild)</li>
                            <li>• Diarrhea (4-6%, mild)</li>
                            <li>• All mild to moderate severity</li>
                        </ul>
                    </div>

                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700">
                        <h3 class="text-lg font-light text-gray-900 dark:text-white mb-4">✓ No Safety Signals</h3>
                        <ul class="space-y-2 text-sm text-gray-600 dark:text-gray-400">
                            <li>• No liver enzyme elevations</li>
                            <li>• No CK elevations</li>
                            <li>• No glucose/glycemic effects</li>
                            <li>• No myalgia signals</li>
                        </ul>
                    </div>
                </div>
            </div>

            <!-- Regulatory Tab -->
            <div class="tab-content hidden" id="regulatory">
                <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700">
                    <h3 class="text-xl font-light text-gray-900 dark:text-white mb-6">FDA/EMA Regulatory Timeline</h3>
                    
                    <div class="relative pl-8">
                        <!-- Timeline line -->
                        <div class="absolute left-3 top-0 bottom-0 w-0.5 bg-gradient-to-b from-transparent via-indigo-300 dark:via-indigo-600 to-transparent"></div>
                        
                        <!-- Timeline items -->
                        <div class="relative mb-8">
                            <div class="absolute -left-5 w-4 h-4 bg-indigo-500 rounded-full border-2 border-white dark:border-gray-900"></div>
                            <div class="ml-6 p-4 bg-white dark:bg-gray-800 rounded-lg shadow-md">
                                <div class="text-xs font-medium text-indigo-600 dark:text-indigo-400 mb-1">2023</div>
                                <div class="text-sm font-medium text-gray-900 dark:text-white mb-2">Phase I Initiation & UK Innovation Passport</div>
                                <div class="text-xs text-gray-600 dark:text-gray-400">
                                    52% LDL-C reduction achieved on top of rosuvastatin. UK MHRA granted Innovation Passport.
                                </div>
                            </div>
                        </div>

                        <div class="relative mb-8">
                            <div class="absolute -left-5 w-4 h-4 bg-indigo-500 rounded-full border-2 border-white dark:border-gray-900"></div>
                            <div class="ml-6 p-4 bg-white dark:bg-gray-800 rounded-lg shadow-md">
                                <div class="text-xs font-medium text-indigo-600 dark:text-indigo-400 mb-1">March 31, 2025</div>
                                <div class="text-sm font-medium text-gray-900 dark:text-white mb-2">Phase IIb PURSUIT Results</div>
                                <div class="text-xs text-gray-600 dark:text-gray-400">
                                    50.7% LDL reduction confirmed. 84% of patients achieved guideline goals.
                                </div>
                            </div>
                        </div>

                        <div class="relative mb-8">
                            <div class="absolute -left-5 w-4 h-4 bg-amber-500 rounded-full border-2 border-white dark:border-gray-900"></div>
                            <div class="ml-6 p-4 bg-white dark:bg-gray-800 rounded-lg shadow-md">
                                <div class="text-xs font-medium text-amber-600 dark:text-amber-400 mb-1">May-June 2025</div>
                                <div class="text-sm font-medium text-gray-900 dark:text-white mb-2">Phase III Program Launch</div>
                                <div class="text-xs text-gray-600 dark:text-gray-400">
                                    Multiple Phase III trials initiated. Total enrollment >13,000 patients.
                                </div>
                            </div>
                        </div>

                        <div class="relative mb-8">
                            <div class="absolute -left-5 w-4 h-4 bg-gray-400 rounded-full border-2 border-white dark:border-gray-900"></div>
                            <div class="ml-6 p-4 bg-white dark:bg-gray-800 rounded-lg shadow-md border-2 border-dashed border-gray-300 dark:border-gray-600">
                                <div class="text-xs font-medium text-gray-600 dark:text-gray-400 mb-1">Mid-2027 (Projected)</div>
                                <div class="text-sm font-medium text-gray-900 dark:text-white mb-2">NDA/MAA Filing</div>
                                <div class="text-xs text-gray-600 dark:text-gray-400">
                                    Expected filing with FDA and EMA based on Phase III LDL-C reduction data.
                                </div>
                            </div>
                        </div>

                        <div class="relative">
                            <div class="absolute -left-5 w-4 h-4 bg-gray-400 rounded-full border-2 border-white dark:border-gray-900"></div>
                            <div class="ml-6 p-4 bg-white dark:bg-gray-800 rounded-lg shadow-md border-2 border-dashed border-gray-300 dark:border-gray-600">
                                <div class="text-xs font-medium text-gray-600 dark:text-gray-400 mb-1">2029 (Projected)</div>
                                <div class="text-sm font-medium text-gray-900 dark:text-white mb-2">MACE Outcomes Data</div>
                                <div class="text-xs text-gray-600 dark:text-gray-400">
                                    D7960C00015 trial expected to provide definitive MACE data for expanded indications.
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Commercial Tab -->
            <div class="tab-content hidden" id="commercial">
                <div class="glass rounded-xl p-6 mb-6 border border-gray-200 dark:border-gray-700">
                    <div class="text-3xl font-bold text-indigo-600 dark:text-indigo-400 mb-2">$4,000 - $6,000/year</div>
                    <div class="text-sm text-gray-600 dark:text-gray-400 mb-6">Projected annual cost (potentially discounted for volume vs. injectables)</div>
                    
                    <div class="grid grid-cols-1 md:grid-cols-2 gap-6">
                        <div>
                            <div class="text-2xl font-bold text-gray-900 dark:text-white">$1-5 Billion</div>
                            <div class="text-sm text-gray-600 dark:text-gray-400">Market potential by 2030</div>
                        </div>
                        <div>
                            <div class="text-2xl font-bold text-gray-900 dark:text-white">70-80%</div>
                            <div class="text-sm text-gray-600 dark:text-gray-400">Expected PA denial rate initially</div>
                        </div>
                    </div>
                </div>

                <div class="grid grid-cols-1 md:grid-cols-3 gap-6">
                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700">
                        <h3 class="text-lg font-light text-gray-900 dark:text-white mb-4">💰 Payer Considerations</h3>
                        <ul class="space-y-2 text-sm text-gray-600 dark:text-gray-400">
                            <li>• Initially restricted to high-risk</li>
                            <li>• Similar PA requirements to mAbs</li>
                            <li>• Pharmacy benefit eases access</li>
                            <li>• Outcomes data key for coverage</li>
                        </ul>
                    </div>

                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700">
                        <h3 class="text-lg font-light text-gray-900 dark:text-white mb-4">🏥 Market Access</h3>
                        <ul class="space-y-2 text-sm text-gray-600 dark:text-gray-400">
                            <li>• Broader GP use vs. specialists</li>
                            <li>• Adherence programs needed</li>
                            <li>• Fixed-dose combinations</li>
                            <li>• Menarini EU partnership</li>
                        </ul>
                    </div>

                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700">
                        <h3 class="text-lg font-light text-gray-900 dark:text-white mb-4">🎯 Competition</h3>
                        <ul class="space-y-2 text-sm text-gray-600 dark:text-gray-400">
                            <li>• vs. Merck's MK-0616</li>
                            <li>• Small molecule advantage</li>
                            <li>• AZ CV portfolio bundling</li>
                            <li>• Manufacturing scalability</li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <!-- JavaScript -->
    <script>
        function toggleTheme() {
            document.body.classList.toggle('dark');
            localStorage.setItem('theme', document.body.classList.contains('dark') ? 'dark' : 'light');
        }

        // Load saved theme
        if (localStorage.getItem('theme') === 'dark' || (!localStorage.getItem('theme') && window.matchMedia('(prefers-color-scheme: dark)').matches)) {
            document.body.classList.add('dark');
        }

        function showTab(tabName) {
            // Hide all tabs
            const tabs = document.querySelectorAll('.tab-content');
            tabs.forEach(tab => {
                tab.classList.add('hidden');
            });
            
            // Show selected tab
            document.getElementById(tabName).classList.remove('hidden');
            
            // Update nav tabs
            const navTabs = document.querySelectorAll('.nav-tab');
            navTabs.forEach(tab => {
                tab.classList.remove('text-indigo-600', 'dark:text-indigo-400', 'border-b-2', 'border-indigo-600', 'dark:border-indigo-400');
                tab.classList.add('text-gray-600', 'dark:text-gray-400');
            });
            
            // Highlight active tab
            event.target.classList.remove('text-gray-600', 'dark:text-gray-400');
            event.target.classList.add('text-indigo-600', 'dark:text-indigo-400', 'border-b-2', 'border-indigo-600', 'dark:border-indigo-400');
        }
    </script>
</body>
</html>